Direct thrombin inhibitors for percutaneous coronary intervention in the current era of platelet glycoprotein IIb/IIIa inhibition

J Interv Cardiol. 2002 Apr;15(2):141-6. doi: 10.1111/j.1540-8183.2002.tb01046.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary* / adverse effects
  • Angioplasty, Balloon, Coronary* / methods
  • Arginine / analogs & derivatives
  • Coronary Thrombosis / etiology
  • Coronary Thrombosis / prevention & control*
  • Drug Therapy, Combination
  • Fibrinolytic Agents / therapeutic use*
  • Hirudin Therapy
  • Hirudins / analogs & derivatives*
  • Humans
  • Peptide Fragments / therapeutic use
  • Pipecolic Acids / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Recombinant Proteins / therapeutic use
  • Sulfonamides

Substances

  • Fibrinolytic Agents
  • Hirudins
  • Peptide Fragments
  • Pipecolic Acids
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Recombinant Proteins
  • Sulfonamides
  • Arginine
  • argatroban
  • bivalirudin